Psilocybin or Nicotine Patch for Smoking Cessation - A Pilot Randomized Clinical Trial

March 11, 2026 by jamanetwork.com

Psilocybin or Nicotine Patch for Smoking Cessation - A Pilot Randomized Clinical Trial

What tobacco smoking cessation rates does psilocybin, an experimental treatment, yield compared with nicotine patch, an established treatment, with individuals in both groups receiving standardized cognitive behavioral therapy? In a randomized clinical trial, 42 participants randomized to receive psilocybin had more than 6 times greater odds of prolonged smoking abstinence 6 months after treatment than 40 participants who received the nicotine patch. The results suggest that psilocybin holds potential in the treatment of tobacco use disorder and, along with other psychedelics, should be investigated further for tobacco and other substance use disorders.


World map

Categories:


TOP NEWS by REGION

July 27, 2023, 1:04 p.m. by news-medical.net

Tobacco dependence more likely in cigarette smokers, study reveals

Regions: Global

July 28, 2023, 11:16 a.m. by linkedin.com

Forecasting Nicotine Pouches Market till 2023-2030

Regions: Global

July 30, 2023, 11:33 p.m. by regulatorwatch.com

Vital Warning | WHO Is Coming for Your Vapes at COP10 | RegWatch

Regions: Global

July 30, 2023, 8:51 p.m. by colinmendelsohn.com.au

Stop Smoking Start Vaping e-book now free

Regions: Global

Aug. 8, 2023, 9:45 a.m. by insidesources.com

WHO Has Changed Course on Harm Reduction Before; It Must Do So Again

Regions: Global